TRASTUZUMAB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 476 adverse event reports in the FDA FAERS database where TRASTUZUMAB was used for Neoplasm malignant.
Most Reported Side Effects for TRASTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 4,996 | 10.7% | 484 | 2,202 |
| Off label use | 3,802 | 8.2% | 801 | 1,145 |
| Nausea | 3,499 | 7.5% | 402 | 1,460 |
| Fatigue | 3,417 | 7.3% | 444 | 1,306 |
| Myelosuppression | 2,552 | 5.5% | 10 | 1,110 |
| Disease progression | 2,449 | 5.3% | 689 | 462 |
| Death | 2,378 | 5.1% | 2,376 | 236 |
| Vomiting | 2,244 | 4.8% | 265 | 1,146 |
| Dyspnoea | 2,010 | 4.3% | 233 | 1,046 |
| Pyrexia | 1,886 | 4.1% | 192 | 1,067 |
| Asthenia | 1,835 | 3.9% | 300 | 708 |
| Neuropathy peripheral | 1,733 | 3.7% | 228 | 495 |
| Neutropenia | 1,627 | 3.5% | 240 | 530 |
| Ejection fraction decreased | 1,579 | 3.4% | 157 | 417 |
| Alopecia | 1,464 | 3.2% | 170 | 324 |
Other Indications for TRASTUZUMAB
Breast cancer (15,522)
Breast cancer metastatic (6,303)
Product used for unknown indication (5,641)
Her2 positive breast cancer (5,549)
Her-2 positive breast cancer (3,520)
Invasive ductal breast carcinoma (1,576)
Breast cancer female (1,068)
Gastric cancer (917)
Invasive breast carcinoma (489)
Adenocarcinoma gastric (423)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)